FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns

Hits: 13

The FDA is slated to make a decision on whether to approve Pfizer’s shot in August before respiratory syncytial virus season in the fall.  Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


eleven − nine =